By far, the most hard-working employee of the UBC BioBank! #UBCBioBank #biobanking #barcoding #barcodes #workworkwork
UBC BioBank’s Post
More Relevant Posts
-
Learn more about super-secondary structures: https://lnkd.in/d93X3XB7 #ditki #biochemistry #usmle #mcat #proteins #betamotifs #alphamotifs #zincfinger #studybiochem #biochem #biochemtutorials #biochemhelp #combinationmotifs
To view or add a comment, sign in
-
How do you make sure that biological material and data collections are of appropriate quality? If the biobank is accredited by ANAB, then that means the organization is meeting requirements for consistent operation and quality control. #biologicalmaterial #datacollection #biobanking #anab
To view or add a comment, sign in
-
❓What are the differences between Strep-Tactin® and Strep-Tactin®XT? The two engineered Streptavidin variants, Strep-Tactin® and its high-affinity counterpart Strep-Tactin®XT, differ in their binding affinities towards Strep-tag® and Twin-Strep-tag® peptides, as well as usability in different analytical applications, protein purification efficiency, yield, costs per mg of protein, and resin stability. ➡️ Learn more about the differences between the two ligands here: https://lnkd.in/dRjAptMW #biotech #biotechnology #proteinpurification #affinitychromatography #streptag
To view or add a comment, sign in
-
The U.S. Department of Agriculture has approved "Badger G," a genetically modified hemp variant developed by the University of Wisconsin, designed to maximize levels of CBG (cannabigerol) while eliminating THC and CBD. This breakthrough addresses the high cost of producing CBG, known as the "mother" cannabinoid for its foundational role in cannabinoid biosynthesis and potential health benefits, by enabling cultivation of hemp with significantly higher CBG yields. This new variety is expected to revolutionize the hemp market by mitigating the risk of THC regulatory non-compliance for farmers and reducing the reliance on large quantities of hemp biomass for CBG extraction, thereby decreasing production costs. In addition, these advancements could lead to more affordable and innovative CBG + CBD products by enhancing product formulation options and cost-effectiveness. Ultimately, this development has the potential to significantly lower costs for end consumers as well, making CBG more accessible and encouraging the introduction of a wider range of cannabinoid-based health and wellness products. Read more about this groundbreaking innovation in hemp at Hemp Today. https://lnkd.in/gfiFMC_3 #SustainableAgriculture #Biotechnology #AgriculturalInnovation #CannabisIndustry #PlantScience
To view or add a comment, sign in
-
🥚 Boost your egg-citement! Discover how AO-Biotics® EQE is cracking the code to higher egg quality and profitability. 🐓✨ Dive into the details at https://lnkd.in/gs2fWgBk and unlock the potential for your operation! 🌱 Read the article here: https://lnkd.in/ekiScMY8 #BIOZYME
To view or add a comment, sign in
-
China: Chemical structures, biosynthesis, bioactivities, and utilisation values for the diterpenes produced in tobacco trichomes
Chemical structures, biosynthesis, bioactivities, and utilisation values for the diterpenes produced in tobacco trichomes
sciencedirect.com
To view or add a comment, sign in
-
This was quite a track record of performance for Cybin over the past year: - Positive phase 2 safety and efficacy readout for CYB003 as an adjunctive treatment for MDD - Around 75% of MDD patients in remission after just two doses - sustained for at least 4 months - Breakthrough Therapy Designation awarded to CYB003 by FDA - Successful recruitment of 30 sites for an upcoming phase 3 study of CYB003 in MDD this summer - Closing and integration of the Small Pharma team, along with programs and IP - Acceleration of CYB004 IM formulation aimed at delivering a 90 minute experience - Initiation of a phase 2 study of CYB004 in GAD with top line results expected around year end 2024
#Cybin has evolved into a mature, late-stage company with critical milestones on the near-term horizon. With #FDA #BTD designation and positive four-month durability data for #CYB003 and the initiation of our Phase 2 study of #CYB004, we are rapidly advancing our mission to change the treatment paradigm for #MDD and #GAD and bring innovative treatment options to patients in need. —Cybin CEO Doug Drysdale Read our full release on fiscal year 2024 and recent business highlights: https://loom.ly/4r6Nng0 #MentalHealthInnovation #Biotechnology #Psychedelics
To view or add a comment, sign in
-
Recent developments in the production of prebiotic #fructooligosaccharides using #fungal #fructosyltransferases https://lnkd.in/gUVj57B5
To view or add a comment, sign in
-
In addition to the previous post, I created a dynamic visualization🎥 using PyMol to illustrate the simulated frames of the protein. This journey has been incredibly rewarding, and I look forward to the next steps. Stay tuned for more updates. #Bioinformatics #Protein #PyMol #DynamicVisualization
To view or add a comment, sign in
-
New trends for a classical enzyme: Papain, a biotechnological success story in the food industry https://buff.ly/3n2NoKn #Cysteine-proteases #Papain #Enzyme-biotechnology #Biocatalysis #Immobilization #Industrial-processes #INVESTIGARCUC #INVESTIGARUNICOSTA #UNICOSTA
To view or add a comment, sign in
71 followers